Published in Women's Health Weekly, April 12th, 2007
"The immunoexpression of PPARgamma and its putative target cyclo-oxygenase 2 (COX2) was investigated in tumor tissues from 80 patients with primary and corresponding recurrent ovarian serous carcinomas after...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.